Development of Generic Drugs & Innovative Galenical Formulations
Select your language
Choisissez votre langue
15.10.07 : CLL Pharma Receives Notice of a U.S. Patent Allowance for the use of its Pep:trans technology in the field of vaccination
Nice, France—September 19th, 2007 – CLL Pharma, a pharmaceutical R&D Company, today announced that t...
15.10.07 : BTG acquires novel opioid agonist for post-operative pain control from CLL Pharma
London, UK 20 February 2007: BTG plc (LSE: BGC), the medical innovations company, today announces th...
Don't hesitate to contact us for further information.